• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

默克尔细胞癌：ESMO-EURACAN 临床实践指南：诊断、治疗和随访。

Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

机构信息

Department of Early Phase Clinical Trials, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Department of Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital of Essen, Essen; Department of Translational Skin Cancer Research, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.

出版信息

ESMO Open. 2024 May;9(5):102977. doi: 10.1016/j.esmoop.2024.102977. Epub 2024 Apr 30.

DOI:10.1016/j.esmoop.2024.102977
PMID:38796285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11145756/
Abstract

• This ESMO Clinical Practice Guideline provides key recommendations for managing Merkel-cell carcinoma (MCC). • Recommendations are based on available scientific data and the multidisciplinary group of experts’ collective opinion. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Algorithms for the management of locoregional and inoperable/metastatic disease are provided. • A multidisciplinary team with a high level of expertise in MCC should diagnose and make decisions about therapy.

摘要

• 本 ESMO 临床实践指南提供了管理 Merkel 细胞癌 (MCC) 的关键建议。 • 建议基于现有科学数据和多学科专家组的集体意见。 • 该指南涵盖了临床和病理诊断、分期和风险评估、治疗和随访。 • 提供了局部区域和不可手术/转移性疾病管理的算法。 • 应由具有 MCC 专业知识的多学科团队进行诊断和制定治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d57/11145756/e362aad72189/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d57/11145756/73ac2e68e647/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d57/11145756/e362aad72189/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d57/11145756/73ac2e68e647/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d57/11145756/e362aad72189/gr2.jpg

相似文献

1
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.默克尔细胞癌：ESMO-EURACAN 临床实践指南：诊断、治疗和随访。
ESMO Open. 2024 May;9(5):102977. doi: 10.1016/j.esmoop.2024.102977. Epub 2024 Apr 30.
2
Merkel Cell Carcinoma: Updates on Staging and Management.默克尔细胞癌：分期和治疗的最新进展。
Dermatol Clin. 2019 Jul;37(3):269-277. doi: 10.1016/j.det.2019.03.001. Epub 2019 Apr 19.
3
Clinical recognition, diagnosis, and staging of merkel cell carcinoma, and the role of the multidisciplinary management team.默克尔细胞癌的临床识别、诊断与分期以及多学科管理团队的作用。
Curr Probl Cancer. 2010 Jan-Feb;34(1):38-46. doi: 10.1016/j.currproblcancer.2010.01.002.
4
Overview of Merkel cell carcinoma and recent advances in research.默克尔细胞癌概述及研究新进展
Int J Dermatol. 2003 Sep;42(9):669-76. doi: 10.1046/j.1365-4362.2003.01912.x.
5
Diagnosis and Treatment of Merkel Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline of the Spanish Academy of Dermatology and Venereology.专业皮肤科单位中默克尔细胞癌的诊断与治疗：西班牙皮肤病学与性病学学会临床实践指南
Actas Dermosifiliogr (Engl Ed). 2019 Jul-Aug;110(6):460-468. doi: 10.1016/j.ad.2019.01.006. Epub 2019 Apr 5.
6
Merkel cell carcinoma.默克尔细胞癌。
Ann Oncol. 2010 Oct;21 Suppl 7:vii81-5. doi: 10.1093/annonc/mdq366.
7
Merkel cell carcinoma.默克尔细胞癌
Adv Dermatol. 2003;19:185-205.
8
[Merkel cell neoplasm unveiled].[默克尔细胞肿瘤揭秘]
Gan To Kagaku Ryoho. 2010 Apr;37(4):634-7.
9
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma).皮肤神经内分泌癌（默克尔细胞癌）的临床诊疗方法
Cancer Control. 2000 Jan-Feb;7(1):72-83.
10
[Cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].[皮肤神经内分泌癌（默克尔细胞癌）。德国皮肤病学会质量保证委员会及德国皮肤科医生专业组织]
Hautarzt. 1998 Oct;48 Suppl 1:S27-9.

引用本文的文献

1
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).瑞替凡利单抗用于复发性局部晚期或转移性默克尔细胞癌患者的II期研究（POD1UM-201）。
J Immunother Cancer. 2025 Aug 11;13(8):e012478. doi: 10.1136/jitc-2025-012478.
2
Immune-Checkpoint Inhibitors in Lung Neuroendocrine Tumors - A Systematic Review and Meta-Analysis.肺神经内分泌肿瘤中的免疫检查点抑制剂——一项系统评价与荟萃分析
Onco Targets Ther. 2025 Jul 31;18:833-843. doi: 10.2147/OTT.S515194. eCollection 2025.
3
Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases.

本文引用的文献

1
Avelumab for Advanced Merkel Cell Carcinoma: Global Real-World Data on Patient Response and Survival.阿维鲁单抗治疗晚期默克尔细胞癌：关于患者反应和生存的全球真实世界数据。
Pragmat Obs Res. 2023 Nov 16;14:149-154. doi: 10.2147/POR.S398151. eCollection 2023.
2
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT-confirmed complete response.avelumab 治疗转移性 Merkel 细胞癌患者，在 1 年后和 PET/CT 确认完全缓解后可以安全停药。
Cancer. 2024 Feb 1;130(3):433-438. doi: 10.1002/cncr.35050. Epub 2023 Oct 3.
3
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
默克尔细胞癌：聚焦于骨和骨髓转移的最新综述
Cancers (Basel). 2025 Jul 6;17(13):2253. doi: 10.3390/cancers17132253.
4
Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors.使用生长抑素类似物进行肽受体放射性核素治疗，治疗范围超出胃肠胰神经内分泌肿瘤。
J Neuroendocrinol. 2025 Mar;37(3):e70013. doi: 10.1111/jne.70013. Epub 2025 Mar 10.
纳武利尤单抗辅助免疫治疗与观察用于完全切除的 Merkel 细胞癌（ADMEC-O）：来自一项随机、开放标签、2 期试验的无病生存结果。
Lancet. 2023 Sep 2;402(10404):798-808. doi: 10.1016/S0140-6736(23)00769-9. Epub 2023 Jul 11.
4
Merkel Cell Carcinoma-Update on Diagnosis, Management and Future Perspectives.Merkel细胞癌——诊断、治疗及未来展望的最新进展
Cancers (Basel). 2022 Dec 23;15(1):103. doi: 10.3390/cancers15010103.
5
Baseline ultrasound and FDG-PET/CT imaging in Merkel cell carcinoma.默克尔细胞癌的基线超声和 FDG-PET/CT 影像学。
J Surg Oncol. 2023 Apr;127(5):841-847. doi: 10.1002/jso.27193. Epub 2022 Dec 27.
6
Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma.默克尔细胞多瘤病毒感染与默克尔细胞癌的流行病学
Cancers (Basel). 2022 Dec 14;14(24):6176. doi: 10.3390/cancers14246176.
7
Treatment and survival outcomes in metastatic Merkel cell carcinoma: Analysis of 2010 patients from the SEER database.转移性默克尔细胞癌的治疗与生存结局：来自监测、流行病学和最终结果（SEER）数据库的2010例患者分析
Cancer Treat Res Commun. 2022;33:100665. doi: 10.1016/j.ctarc.2022.100665. Epub 2022 Nov 24.
8
Merkel cell carcinoma: Epidemiology, disease presentation, and current clinical practice outcomes.默克尔细胞癌：流行病学、疾病表现及当前临床实践结果。
JAAD Int. 2022 Jun 17;9:128-136. doi: 10.1016/j.jdin.2022.06.004. eCollection 2022 Dec.
9
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.原发部位不明且无远处转移的结节性默克尔细胞癌：单中心病例系列
Cancers (Basel). 2022 Sep 29;14(19):4777. doi: 10.3390/cancers14194777.
10
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.纳武利尤单抗联合伊匹单抗联合或不联合立体定向体部放疗治疗晚期 Merkel 细胞癌：一项随机、开放标签、Ⅱ期临床试验。
Lancet. 2022 Sep 24;400(10357):1008-1019. doi: 10.1016/S0140-6736(22)01659-2. Epub 2022 Sep 12.